KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Liabilities and Shareholders Equity (2017 - 2025)

Guardant Health's Liabilities and Shareholders Equity history spans 9 years, with the latest figure at $2.0 billion for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 35.54% year-over-year to $2.0 billion; the TTM value through Dec 2025 reached $6.0 billion, down 5.86%, while the annual FY2025 figure was $2.0 billion, 35.54% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $2.0 billion at Guardant Health, up from $1.3 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $2.3 billion in Q1 2021 and bottomed at $1.3 billion in Q3 2025.
  • The 5-year median for Liabilities and Shareholders Equity is $1.7 billion (2023), against an average of $1.8 billion.
  • The largest annual shift saw Liabilities and Shareholders Equity surged 147.5% in 2021 before it dropped 29.02% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $2.2 billion in 2021, then dropped by 26.97% to $1.6 billion in 2022, then grew by 10.96% to $1.8 billion in 2023, then decreased by 16.84% to $1.5 billion in 2024, then surged by 35.54% to $2.0 billion in 2025.
  • Per Business Quant, the three most recent readings for GH's Liabilities and Shareholders Equity are $2.0 billion (Q4 2025), $1.3 billion (Q3 2025), and $1.3 billion (Q2 2025).